(702) 683-8946

Monday - Friday 9am to 5pm

triangle
ad1

http://crweworld.com/assets/images/ad/crwe_tech.jpg

Your Technology Source, Your Technology Team

Server Maintenance, Web Development, Mobile Application Solutions, SEO Services and more

Contact Us: contact@crwetech.com

www.CRWETech.com

ad2

http://crweworld.com/assets/images/ad/ad4.png

Place Your Ad Here! Advertise your business online on CRWE WORLD. Your Company, product, or service in front of the world!

Contact Us: contact@crweworld.com

www.CRWEWorld.com

ad3

http://crweworld.com/assets/img/crwe_info.png

CRWE Info ( CRWE.Info ) provides news and updates about Crown Equity Holdings Inc. and the CRWE World platform

www.crwe.info

ad4

http://crweworld.com/assets/images/ad/submit_a_press_release.jpg

Submit Your Press Release/News to the CRWE WORLD Network for $14.95! Increase Visibility, Boost Your Business

www.CRWEPressRelease.com

ad5

http://crweworld.com/assets/images/ad/Pathology_Laboratories.png

Quest Diagnostics Inc. (NYSE:DGX) offers the most extensive clinical testing network in the U.S. The Company's extensive test menu includes routine biological testing; complex and specialized molecular and gene-based testing, and anatomic pathology testing. These services primarily help identify disease or risk factors for disease and predict and monitor response to treatment.

www.QuestDiagnostics.com






6 Result: KITE

Nivalis Therapeutics and Alpine Immune Sciences Agree to Combine

April 18th, 2017

- Plan to Accelerate Development of Novel Immunotherapies Focused on Inflammation and Immuno-Oncology - - Combined Company Well Capitalized with $90 Million in Funding to Advance Discovery and Development - - Existing Investors OrbiMed Advisors. Read more

HIV/HPV Guru Comes on Board to Battle Cancer, Driving CEL-SCI's Multi-billion Dollar Market Opportunity

July 28th, 2015

NEW YORK, NY / CRWEPRESSRELEASE / July 28, 2015 / Advancing promising clinical research past government funded trials is big milestone for biotechs and often comes with a corresponding move in the company's inherent value. This is especially so when . Read more

Heat Biologics: Immunotherapy Vaccine to Transform Cancer Treatment

July 16th, 2015

NEW YORK, NY / CRWEPRESSRELEASE / July 16, 2015 / We all know that cancer affects many of our friends and family, but why don't we all get cancer? We now know that our immune system is continuously fighting and destroying potential cancer cells.Wh. Read more

CEL-SCI is a Rare Value Opportunity in Cancer Immunotherapy Stocks

April 23rd, 2015

NEW YORK, NY / CRWEPRESSRELEASE / April 23, 2015 / Cancer immunotherapy is scorching hot. At no time in medical history has a new cancer treatment been so widely researched and highly paid for. Over the last 50 years, the only medicine for cancer has. Read more

Cel-Sci's Cancer Immunotherapy In Phase III Is Value Opportunity

March 12th, 2015

BALTIMORE, MD / CRWEPRESSRELEASE / March 12, 2015 / Cancer immunotherapy has become today's word for treating patients with death-causing diseases, but progress and valuations within companies run a broad course. In this article, I will explain to in. Read more

The Ultimate Kitesurfing Escape

January 15th, 2015

ANGUILLA, BWI / CRWEPRESSRELEASE / JANUARY 15, 2015 / Ani Villas Anguilla, the luxury Caribbean hideaway, partners with Private Jet Services Group and Anguilla Watersports Ltd. to offer the ultimate action-packed, super luxurious vacation for thrill-. Read more

Load More Content